Business Description
Chugai Pharmaceutical Co Ltd
NAICS : 325412
ISIN : JP3519400000
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.84 | |||||
Interest Coverage | 13737.44 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 23.1 | |||||
Beneish M-Score | -1.98 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.4 | |||||
3-Year EBITDA Growth Rate | 36.7 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 5.9 | |||||
3-Year Book Growth Rate | 18.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 2.92 | |||||
Future 3-5Y Total Revenue Growth Rate | 0.99 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.6 | |||||
9-Day RSI | 50.62 | |||||
14-Day RSI | 54.48 | |||||
6-1 Month Momentum % | 30.42 | |||||
12-1 Month Momentum % | 75.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.76 | |||||
Quick Ratio | 3.71 | |||||
Cash Ratio | 2.34 | |||||
Days Inventory | 195.15 | |||||
Days Sales Outstanding | 100.62 | |||||
Days Payable | 105.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.34 | |||||
Dividend Payout Ratio | 0.39 | |||||
3-Year Dividend Growth Rate | 34.6 | |||||
Forward Dividend Yield % | 1.37 | |||||
5-Year Yield-on-Cost % | 6.68 | |||||
Shareholder Yield % | 1.34 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.15 | |||||
Operating Margin % | 36.6 | |||||
Net Margin % | 26.39 | |||||
FCF Margin % | 14.98 | |||||
ROE % | 23.33 | |||||
ROA % | 18.73 | |||||
ROIC % | 32.9 | |||||
ROC (Joel Greenblatt) % | 63.5 | |||||
ROCE % | 32.12 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.03 | |||||
Forward PE Ratio | 28.9 | |||||
PE Ratio without NRI | 30.03 | |||||
Shiller PE Ratio | 57.41 | |||||
Price-to-Owner-Earnings | 51.15 | |||||
PEG Ratio | 0.7 | |||||
PS Ratio | 7.92 | |||||
PB Ratio | 6.59 | |||||
Price-to-Tangible-Book | 6.67 | |||||
Price-to-Free-Cash-Flow | 52.88 | |||||
Price-to-Operating-Cash-Flow | 39 | |||||
EV-to-EBIT | 20.18 | |||||
EV-to-Forward-EBIT | 20.56 | |||||
EV-to-EBITDA | 20.18 | |||||
EV-to-Forward-EBITDA | 19.11 | |||||
EV-to-Revenue | 7.44 | |||||
EV-to-Forward-Revenue | 8.43 | |||||
EV-to-FCF | 48.23 | |||||
Price-to-Projected-FCF | 2.85 | |||||
Price-to-DCF (Earnings Based) | 0.64 | |||||
Price-to-DCF (FCF Based) | 1.13 | |||||
Price-to-Median-PS-Value | 1.45 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.2 | |||||
Price-to-Graham-Number | 2.98 | |||||
Price-to-Net-Current-Asset-Value | 10.37 | |||||
Price-to-Net-Cash | 30.06 | |||||
Earnings Yield (Greenblatt) % | 4.96 | |||||
FCF Yield % | 1.89 | |||||
Forward Rate of Return (Yacktman) % | 21.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Chugai Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 1,276,270 | ||
EPS (TTM) (円) | 204.65 | ||
Beta | 0.76 | ||
Volatility % | 21.1 | ||
14-Day RSI | 54.48 | ||
14-Day ATR (円) | 193.203901 | ||
20-Day SMA (円) | 6127.6 | ||
12-1 Month Momentum % | 75.4 | ||
52-Week Range (円) | 3203 - 6697 | ||
Shares Outstanding (Mil) | 1,645.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chugai Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chugai Pharmaceutical Co Ltd Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Chugai Pharmaceutical Co Ltd Frequently Asked Questions
What is Chugai Pharmaceutical Co Ltd(TSE:4519)'s stock price today?
When is next earnings date of Chugai Pharmaceutical Co Ltd(TSE:4519)?
Does Chugai Pharmaceutical Co Ltd(TSE:4519) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |